As of November 6, 2026, 6 holders' latest Schedule 13D or 13G filings report owning 5% or more of Twist Bioscience Corp. The largest reported stake is Fmr LLC's, at 14.4%. 23 filings are on record since August 7, 2025 (Schedule 13G/A, November 5, 2026).
Sell to companies like Twist Bioscience Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Fmr LLC · Sole voting: 9,519,321 · Shared voting: 0 · Sole dispositive: 9,535,193 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-11-05
- · Reporting person: ARK Investment Management LLC · Sole voting: 3,228,258 · Shared voting: 44,747 · Sole dispositive: 3,385,850 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-09-08
- · Holder: Fmr LLC · Percent: 13.2% · SCHEDULE 13G/A
- · Reporting person: T. Rowe Price Associates, Inc. · Sole voting: 3,520,536 · Shared voting: 0 · Sole dispositive: 3,634,470 · Shared dispositive: 0 · SCHEDULE 13G, 2026-08-14
- · Reporting person: EdgePoint Investment Group Inc. · Sole voting: 1,945,483 · Shared voting: 576,152 · Sole dispositive: 1,945,483 · Shared dispositive: 576,152 · SCHEDULE 13G/A, 2026-08-14
Twist Bioscience Corp has 23 Schedule 13D or 13G filings on record since 2025-08-07. 6 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Fmr LLC | 14.4% | 9,535,193 | SCHEDULE 13G/A, 2026-11-05 | 2026-09-30 |
| Artisan Partners Asset Management Inc. | 7.7% | 4,802,017 | SCHEDULE 13G/A, 2026-08-13 | 2026-06-30 |
| T. Rowe Price Associates, Inc. | 5.8% | 3,634,470 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| ARK Investment Management LLC | 5.11% | 3,385,850 | SCHEDULE 13G/A, 2026-09-08 | 2026-08-31 |
| State Street Corporation | 5.1% | 3,089,063 | SCHEDULE 13G, 2025-11-10 | 2025-09-30 |
| Vanguard Capital Management | 5.05% | 3,101,909 | SCHEDULE 13G, 2026-04-30 | 2026-03-31 |
| EdgePoint Investment Group Inc. | 4.21% | 2,521,635 | SCHEDULE 13G/A, 2026-08-14 | 2026-06-30 |
| Invesco Ltd. | 3.9% | 2,347,929 | SCHEDULE 13G/A, 2025-08-07 | 2025-06-30 |
| William Blair Investment Management, LLC | 3.5% | 2,174,594 | SCHEDULE 13G/A, 2026-08-11 | 2026-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Twist Bioscience Corp and the warning signs.
Free to see. No signup.
Keep reading
More on Twist Bioscience Corp and the records around it.
Twist Bioscience Corp elsewhere on the record
Companies that share a holder
- EdgePoint Investment Group Inc. also filed stake reports on 11 other companies: MATTEL INC /DE/ (Oct 2026), ALGONQUIN POWER & UTILITIES CORP. (Oct 2026), Restaurant Brands International Inc. (Aug 2026)
- Artisan Partners Asset Management Inc. also filed stake reports on 16 other companies: Ascendis Pharma A/S (Aug 2026), AXALTA COATING SYSTEMS LTD. (Aug 2026), iRhythm Holdings, Inc. (Aug 2026)
- ARK Investment Management LLC also filed stake reports on 20 other companies: Tempus AI, Inc. (Nov 2026), 10x Genomics, Inc. (Oct 2026), 908 Devices Inc. (Aug 2026)
Watch Twist Bioscience Corp
Get an email when Twist Bioscience Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Twist Bioscience Corp?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Twist Bioscience Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Twist Bioscience Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
23 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Fmr LLC | 9,519,321 | 0 | 9,535,193 | 0 | SCHEDULE 13G/A, 2026-11-05 |
| Abigail P. Johnson | 0 | 0 | 9,535,193 | 0 | SCHEDULE 13G/A, 2026-11-05 |
| Artisan Partners Asset Management Inc. | 0 | 4,215,805 | 0 | 4,802,017 | SCHEDULE 13G/A, 2026-08-13 |
| Artisan Partners Holdings LP | 0 | 4,215,805 | 0 | 4,802,017 | SCHEDULE 13G/A, 2026-08-13 |
| Artisan Investments GP LLC | 0 | 4,215,805 | 0 | 4,802,017 | SCHEDULE 13G/A, 2026-08-13 |
| Artisan Partners Limited Partnership | 0 | 4,215,805 | 0 | 4,802,017 | SCHEDULE 13G/A, 2026-08-13 |
| T. Rowe Price Associates, Inc. | 3,520,536 | 0 | 3,634,470 | 0 | SCHEDULE 13G, 2026-08-14 |
| ARK Investment Management LLC | 3,228,258 | 44,747 | 3,385,850 | 0 | SCHEDULE 13G/A, 2026-09-08 |
| Catherine D. Wood | 0 | 3,273,005 | 0 | 3,385,850 | SCHEDULE 13G/A, 2026-09-08 |
| EdgePoint Investment Group Inc. | 1,945,483 | 576,152 | 1,945,483 | 576,152 | SCHEDULE 13G/A, 2026-08-14 |
| William Blair Investment Management, LLC | 1,975,454 | 0 | 2,174,594 | 0 | SCHEDULE 13G/A, 2026-08-11 |
The latest filing identifies Twist Bioscience Corp by CUSIP 90184D100 and gives its principal executive office as 681 GATEWAY BLVD, South San Francisco, CA 94080 (SCHEDULE 13G/A, 2026-11-05).
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-08-07 | Invesco Ltd. | 3.9% | SCHEDULE 13G/A |
| 2025-08-12 | Artisan Partners Asset Management Inc. | 8.4% | SCHEDULE 13G/A |
| 2025-10-07 | Artisan Partners Asset Management Inc. | 10.6% | SCHEDULE 13G/A |
| 2025-11-10 | State Street Corporation | 5.1% | SCHEDULE 13G |
| 2025-11-14 | EdgePoint Investment Group Inc. | 6.76% | SCHEDULE 13G |
| 2026-02-03 | ARK Investment Management LLC | 12.36% | SCHEDULE 13G/A |
| 2026-02-03 | Artisan Partners Asset Management Inc. | 9.5% | SCHEDULE 13G/A |
| 2026-02-09 | William Blair Investment Management, LLC | 9.7% | SCHEDULE 13G/A |
| 2026-02-17 | EdgePoint Investment Group Inc. | 8.8% | SCHEDULE 13G/A |
| 2026-03-06 | Artisan Partners Asset Management Inc. | 10.1% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-04-30 | ARK Investment Management LLC | 10.35% | SCHEDULE 13G/A |
| 2026-04-30 | Vanguard Capital Management | 5.05% | SCHEDULE 13G |
| 2026-05-07 | William Blair Investment Management, LLC | 8.6% | SCHEDULE 13G/A |
| 2026-08-06 | Fmr LLC | 7.6% | SCHEDULE 13G |
| 2026-08-11 | William Blair Investment Management, LLC | 3.5% | SCHEDULE 13G/A |
| 2026-08-13 | Artisan Partners Asset Management Inc. | 7.7% | SCHEDULE 13G/A |
| 2026-08-14 | T. Rowe Price Associates, Inc. | 5.8% | SCHEDULE 13G |
| 2026-08-14 | ARK Investment Management LLC | 7.31% | SCHEDULE 13G/A |
| 2026-08-14 | EdgePoint Investment Group Inc. | 4.21% | SCHEDULE 13G/A |
| 2026-09-08 | Fmr LLC | 13.2% | SCHEDULE 13G/A |
| 2026-09-08 | ARK Investment Management LLC | 5.11% | SCHEDULE 13G/A |
| 2026-11-05 | Fmr LLC | 14.4% | SCHEDULE 13G/A |
Questions about who owns Twist Bioscience Corp
Who owns Twist Bioscience Corp?
On this page, 6 holders' latest ownership filings report 5% or more of Twist Bioscience Corp: Fmr LLC (14.4%, Schedule 13G/A, filed 2026-11-05), Artisan Partners Asset Management Inc. (7.7%, Schedule 13G/A, filed 2026-08-13), T. Rowe Price Associates, Inc. (5.8%, Schedule 13G, filed 2026-08-14), ARK Investment Management LLC (5.11%, Schedule 13G/A, filed 2026-09-08) and State Street Corporation (5.1%, Schedule 13G, filed 2025-11-10); 1 more is listed above.
Who are the largest shareholders of Twist Bioscience Corp?
By the share each holder's latest filing reports, the largest holders of Twist Bioscience Corp on this page are Fmr LLC (14.4%), Artisan Partners Asset Management Inc. (7.7%) and T. Rowe Price Associates, Inc. (5.8%).
When did Fmr LLC buy into Twist Bioscience Corp?
The filings give report dates, not purchase dates. The earliest filing from Fmr LLC on this page is the Schedule 13G, filed 2026-08-06, reporting 7.6%; its latest, Schedule 13G/A filed 2026-11-05, reports 14.4%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 23 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Twist Bioscience Corp. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.